|
Altus Pharmaceuticals Inc. - Company Profile Snapshot
| Company Profile: |
Altus Pharmaceuticals Inc. |
| Ticker: |
ALTUQ |
| Exchanges: |
OTC |
| 2008 Sales: |
2,622,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
145 |
Business Description
Altus Pharmaceuticals Inc.. The Group's principal activity is to develop and commercialize oral and injectable protein therapeutics for chronic gastrointestinal and metabolic disorders, with two product candidates in clinical development. It's products are novel therapies that are designed to be safe, effective and convenient resulting in enhanced patient compliance. ALTU-242, is an orally-administered enzyme replacement therapy consisting of three digestive, enzymes, lipase, protease and amylase, for the treatment of malabsorption due to exocrine pancreatic insufficiency.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
